M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals

BACKGROUND: Assessing liver fibrosis is important for predicting the efficacy of direct-acting antivirals (DAAs) and patient prognosis. Non-invasive techniques to assess liver fibrosis are becoming important. Recently, serum Mac-2 binding protein glycosylation isomer (M2BPGi) was identified as a non...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Shereen A, Salama, Mohamed M, Alhusseini, Marwan M, Mohamed, Ghada A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284180/
https://www.ncbi.nlm.nih.gov/pubmed/32550761
http://dx.doi.org/10.3748/wjg.v26.i21.2864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284180/
https://www.ncbi.nlm.nih.gov/pubmed/32550761
http://dx.doi.org/10.3748/wjg.v26.i21.2864

Ejemplares similares